Flarin Holdings appoints CTH to drive globalisation of the world’s first lipid formulated ibuprofen

Flarin Holdings Limited (FHL), trading through its subsidiary Infirst Limited, today announces that it has appointed Capel Thompson & Homer LLP (CTH) as advisor to assist in seeking a licensing partner for its patented lipid NSAID technology in the USA and other geographies.